Strategic Fit Target mid-sized aesthetic device manufacturers and clinics that seek touchless robotic laser capabilities, focusing on expanding their portfolios with EON-like platforms to capture demand in body contouring and fat reduction.

Regulatory Validate Position Dominion as a FDA-cleared, safety-first platform with clinical advisory support to build trust with buyers who require proven efficacy and physician endorsement for reimbursement discussions.

Global Expansion Leverage existing labs in Florida and HQ in Texas to approach multi-region clinics and international distributors, highlighting scalable service and localized training to accelerate deployments.

Partnership Upsell Offer partnerships with clinics and groups that already invest in laser aesthetics by bundling service, maintenance, training, and ongoing updates to increase stickiness and recurring revenue.

Growth Signals Emphasize the company’s $26M funding and rising but modest revenue band to attract growth-minded buyers seeking innovative but cost-justified capital expenditure with clear ROI in body contouring markets.